NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MygeA.00076.a: Uracil phosphoribosyltransferase (MG_030)

Target Characteristics

from organism: Mycoplasma genitalium ATCC 33530 / G-37 / NCTC 10195
most recent status: target approved
center reference id: MygeA.00076.a
is community request: False
associated disease:
NIH risk group: unclassified
is select agent: False
NIH priority
pathogens category:
C

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Molecular models

Method Results
comparative modelling Robetta_10521

External Resources

Resource Reference ID
PATRIC ID: fig|243273.25.peg.28
UniProt: P47276

Enzyme & Pathway Information

Pathway Pathway ID EC Number
purine and pyrimidine metabolism P1-PWY 2.4.2.9
salvage pathways of pyrimidine ribonucleotides PWY0-163 2.4.2.9
pyrimidine nucleobases salvage I PWY-7183 2.4.2.9
pyrimidine nucleobases salvage II PWY-7194 2.4.2.9
superpathway of pyrimidine ribonucleosides salvage PWY-7196 2.4.2.9
superpathway of pyrimidine nucleobases salvage PWY-7208 2.4.2.9

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MIKKVQHALI LNELTKLRDK NTTTSQFRMA LNQITSLLFF EATKQLPLAT VEVETPFAKT KGYKLKNDIV LVPIMRAGLG MIDAIVRYSD KIRVGHLGIY RQTQTTSVIS YYKKMPENIS DSHVIILDPM LATGTTLLTA IKSIKEDKPI KISVIAIVAA PEGINKVEKM HPHVDIFLAA IDEKLNDNRY IIPGLGDAGD RLFGTK

NT Sequence
GTGATAAAAA AAGTTCAACA TGCTTTAATC TTGAATGAAT TGACAAAACT GCGTGATAAA AATACAACAA CCTCCCAGTT TCGCATGGCC TTGAATCAAA TCACTTCATT ACTCTTTTTT GAAGCAACTA AACAGCTACC ACTAGCAACA GTTGAAGTTG AAACTCCCTT TGCTAAAACA AAGGGCTACA AATTAAAAAA TGACATTGTT CTTGTACCTA TTATGCGTGC TGGACTTGGA ATGATTGATG CTATTGTTCG CTATTCAGAT AAAATCAGAG TTGGTCATTT AGGAATCTAT CGTCAAACCC AAACAACCAG TGTAATTTCA TACTATAAAA AGATGCCTGA AAACATCTCT GATTCACATG TTATTATTCT TGATCCTATG CTTGCTACTG GAACTACATT GTTAACTGCT ATTAAATCTA TTAAAGAAGA TAAACCTATC AAAATTAGTG TTATTGCTAT AGTAGCAGCA CCTGAAGGAA TTAATAAAGT AGAAAAAATG CATCCTCATG TTGATATATT TCTTGCAGCA ATTGATGAAA AGTTAAATGA CAATAGATAC ATAATCCCTG GTCTTGGTGA TGCTGGGGAC CGTTTATTTG GTACTAAA

© 2020 Seattle Children's Research Institute. All rights reserved.